SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in FNCHQ — Finch Therapeutics Group, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in FNCHQ
as of Mar 31, 2024
· filed May 7, 2024
Position Value
$153,472
-$59,619 QoQ
Shares Held
59,028
0.0% QoQ
Ownership
3.68%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FNCHQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in FNCHQ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-03-31 | $153,472 | 59,028 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $213,091 | 59,028 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $305,765 | 59,028 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $503,508 | 59,028 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||